Table 2.
Pt | Intravenous treatment1 |
Oral treatment2 | 1st AST | Side effects AST |
Change of treatment |
2nd AST | Side effects AST | Change of treatment |
---|---|---|---|---|---|---|---|---|
1 | Penicillin 12 mU /day | Amoxicillin 1000 mg TID | Amoxicillin 500 mg TID | No | - | - | - | - |
2 | Vancomycin/day3, 4w | Minocycline 100 mg BID | Minocycline 100 mg BID | Nausea, phototoxicity | Yes | Minocycline 100 mg QD | Phototoxicity | No |
3 | Penicillin 12 mU/day | Moxifloxacin 400 mg QD Rifampin4 450 mg BID |
Moxifloxacin 400 mg QD | No | - | - | - | - |
4 | Vancomycin/day3 Ciprofloxacin 400 mg TID |
Ciprofloxacin 750 mg BID Rifampin4 450 mg BID Linezolid 600 mg BID, 4w Mincocyline 100 mg BID, 6w |
Minocycline 100 mg BID | Nausea, vomiting | Yes | Doxycyclin 100 mg QD | No | - |
5 | - | - | Moxifloxacin 400 mg QD | Nausea | No | - | - | - |
6 | Amoxicillin 12 g/day Flucloxacillin 12 g/day Gentamicin 3 mg/kg/day |
Amox/clav 500/125 QID Rifampin4 450 mg BID |
Amox/clav 500/125 mg TID | No | - | - | - | - |
7 | - - |
Metronidazole 500 mg QID Amox/clav 750/125 TID |
Amox/clav 500/125 mg TID | Nausea | Yes | Minocycline 100 mg QD | Dizziness | No |
8 | Vancomycin/day3 | Mincocyline 100 mg BID | Minocycline 100 mg QD | No | - | - | - | - |
9 | Ceftriaxone 2 g QD | Clindamycin 600 mg TID Rifampin4 450 mg BID |
Amoxicillin 500 mg TID | Dry mouth | Yes | Amoxicillin 375 mg TID | Malaise | No |
10 | Flucloxacillin 12 g/day | Moxifloxacin 400 mg QD Rifampin4 450 mg BID |
Clindamycin 450 mg TID | No | - | - | - | - |
11 | - | Linezolid 600 mg BID, 4w Mincocyline 100 mg BID, 8w |
Minocycline 100 mg BID | Diarrhea | Yes | Minocycline 100 mg QD | No | - |
12 | Flucloxacillin 12 g/day | Moxifloxacin 400 mg QD Rifampin4 450 mg BID |
Clindamycin 450 mg TID | Nausea | Yes | Moxifloxacin 400 mg QD | No | - |
13 | Flucloxacillin 12 g/day | Moxifloxacin 400 mg QD Rifampin4 450 mg BID |
Clindamycin 600 mg TID | No | - | - | - | - |
14 | Vancomycin/day3 | Linezolid 600 mg BID, 4w Mincocyline 100 mg BID, 6w |
Minocycline 100 mg QD | No | - | - | - | - |
15 | - | Clindamycin 600 mg TID | Clindamycin 600 mg TID | Loss of appetite | Yes | Clindamycin 300 mg TID | No | - |
16 | Flucloxacillin 8 g5/day, 1w | Clindamycin 600 mg TID | Clindamycin 600 mg TID | No | - | - | - | - |
17 | Daptomycin 8 mg/kg/day6 | Mincocyline 100 mg BID Rifampin4 450 mg BID |
Minocycline 100 mg BID | Skin rash | Yes | Cotrimoxazole 960 mg BID | No | - |
18 | Flucloxacillin 8 g/day5 | Moxifloxacin 400 mg QD Rifampin4 450 mg BID |
Clindamycin 600 mg TID | No | - | - | - | - |
19 | Meropenem 2 g TID Vancomycin/day3 Gentamicin 3 mg/kg/day |
Ciprofloxacin 750 mg BID Amoxicillin 1000 mg TID |
Cotrimoxazole 960 mg BID Amoxicillin 1000 mg TID |
No No |
- - |
- - |
- - |
- - |
20 | Penicillin 12 mU/day, 4w Gentamicin 3 mg/kg/day, 4w |
Amoxicillin 1000 mg TID, 8w | Amoxicillin 500 mg TID | No | - | - | - | - |
21 | - | - | Clindamycin 450 mg TID | No | - | - | - | - |
1 Intravenous treatment comprises 2 weeks of treatment, unless otherwise stated. 2 Oral treatment comprises 10 weeks of treatment, unless otherwise stated. 3 The dose of vancomycin was determined by therapeutic drug monitoring, aiming towards a serum concentration level of ±25 mg/L (continuous infusion). 4 In general, rifampin is added during intravenous treatment after susceptibility is known (after ± 5 days). 5 8 grams of flucloxacillin was chosen because of renal insufficiency. 6 Daptomycin was chosen because of allergy to penicillin.